Search research articles
Contact Us
Filters
Showing results (21-30 of 89) with videos related to
Page
of 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 19, 2019
Systematic Review and Meta-analysis of Treatment Interruptions in Human Immunodeficiency Virus (HIV) Type 1-infected Patients Receiving Antiretroviral Therapy: Implications for Future HIV Cure Trials
Melanie Stecher, Annika Claßen, Florian Klein, et al.
Vaccines
|
December 16, 2020
Lactobacilli Expressing Broadly Neutralizing Nanobodies against HIV-1 as Potential Vectors for HIV-1 Prophylaxis?
Sarah Kalusche, Kanika Vanshylla, Franziska Kleipass, et al.
Viruses
|
August 28, 2021
The Alpha Variant (B.1.1.7) of SARS-CoV-2 in Children: First Experience from 3544 Nucleic Acid Amplification Tests in a Cohort of Children in Germany
Meike Meyer, Anna Holfter, Esra Ruebsteck, et al.
Infection
|
January 5, 2020
Intensified adjunctive corticosteroid therapy for CNS tuberculomas
Isabelle Suárez, Henning Gruell, Jan Heyckendorf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 3, 2017
On Taking a Different Route: An Unlikely Case of Malaria by Nosocomial Transmission
Henning Gruell, Laura Hamacher, Veronika Jennissen, et al.
Frontiers in Immunology
|
January 6, 2022
Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19
Sibylle C Mellinghoff, Kanika Vanshylla, Christine Dahlke, et al.
European Journal of Haematology
|
June 24, 2020
COVID-19 complicated by parainfluenza co-infection in a patient with chronic lymphocytic leukemia
Petra Langerbeins, Moritz Fürstenau, Henning Gruell, et al.
Vaccines
|
March 6, 2021
CD34T+ Humanized Mouse Model to Study Mucosal HIV-1 Transmission and Prevention
Kanika Vanshylla, Kathrin Held, Tabea M Eser, et al.
The Lancet. Infectious Diseases
|
March 3, 2022
Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults
Kanika Vanshylla, Pinkus Tober-Lau, Henning Gruell, et al.
Emerging Infectious Diseases
|
March 8, 2022
Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections
Pinkus Tober-Lau, Henning Gruell, Kanika Vanshylla, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 89) with videos related to
Sort By:
Page
of 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 19, 2019
Systematic Review and Meta-analysis of Treatment Interruptions in Human Immunodeficiency Virus (HIV) Type 1-infected Patients Receiving Antiretroviral Therapy: Implications for Future HIV Cure Trials
Melanie Stecher, Annika Claßen, Florian Klein, et al.
Vaccines
|
December 16, 2020
Lactobacilli Expressing Broadly Neutralizing Nanobodies against HIV-1 as Potential Vectors for HIV-1 Prophylaxis?
Sarah Kalusche, Kanika Vanshylla, Franziska Kleipass, et al.
Viruses
|
August 28, 2021
The Alpha Variant (B.1.1.7) of SARS-CoV-2 in Children: First Experience from 3544 Nucleic Acid Amplification Tests in a Cohort of Children in Germany
Meike Meyer, Anna Holfter, Esra Ruebsteck, et al.
Infection
|
January 5, 2020
Intensified adjunctive corticosteroid therapy for CNS tuberculomas
Isabelle Suárez, Henning Gruell, Jan Heyckendorf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 3, 2017
On Taking a Different Route: An Unlikely Case of Malaria by Nosocomial Transmission
Henning Gruell, Laura Hamacher, Veronika Jennissen, et al.
Frontiers in Immunology
|
January 6, 2022
Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19
Sibylle C Mellinghoff, Kanika Vanshylla, Christine Dahlke, et al.
European Journal of Haematology
|
June 24, 2020
COVID-19 complicated by parainfluenza co-infection in a patient with chronic lymphocytic leukemia
Petra Langerbeins, Moritz Fürstenau, Henning Gruell, et al.
Vaccines
|
March 6, 2021
CD34T+ Humanized Mouse Model to Study Mucosal HIV-1 Transmission and Prevention
Kanika Vanshylla, Kathrin Held, Tabea M Eser, et al.
The Lancet. Infectious Diseases
|
March 3, 2022
Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults
Kanika Vanshylla, Pinkus Tober-Lau, Henning Gruell, et al.
Emerging Infectious Diseases
|
March 8, 2022
Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections
Pinkus Tober-Lau, Henning Gruell, Kanika Vanshylla, et al.
Page
of 9